(20S)-Protopanaxadiol
CAS No. 30636-90-9
(20S)-Protopanaxadiol( 20-Epiprotopanaxadiol | 20(S)-APPD )
Catalog No. M18399 CAS No. 30636-90-9
(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | Get Quote |
|
| 10MG | 58 | Get Quote |
|
| 50MG | 219 | Get Quote |
|
| 100MG | 329 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(20S)-Protopanaxadiol
-
NoteResearch use only, not for human use.
-
Brief Description(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.
-
Description(20S)-Protopanaxadiol (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.
-
In Vitro20S-protopanaxadiol treatment upregulates the flotillin-1 level in the rafts of N2a cells to 142.91±10.71% of the control. 20S-protopanaxadiol can have an opposite effect on raft resident protein flotillin-1, depending on the cell type.
-
In Vivo——
-
Synonyms20-Epiprotopanaxadiol | 20(S)-APPD
-
PathwayNeuroscience
-
TargetGamma-secretase
-
RecptorApoptosis inducer
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number30636-90-9
-
Formula Weight460.39
-
Molecular FormulaC30H52O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL217.05 mMH2O : < 0.1 mg/mL
-
SMILESC1C[C@@H](C([C@@H]2CC[C@]3([C@@]4(CC[C@@H]([C@H]4[C@@H](C[C@@H]3[C@@]12C)O)[C@](C)(CCC=C(C)C)O)C)C)(C)C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu R, et al. Fitoterapia. 2010 Dec;81(8):1079-87.
molnova catalog
related products
-
RO7185876
RO7185876 is a selective gamma secretase modulator, which can be used in the study of Alzheimer's disease.
-
PEAQX
PEAQX(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).
-
Brontictuzumab
Brontictuzumab (OMP 52M5) is a monoclonal antibody that targets Notch1 and inhibits activation of the pathway.
Cart
sales@molnova.com